LM Scaffold System
The LM Scaffold System™ | An Evolution in Tracheobronchomalacia Treatment | By Richard Lazzaro, MD, Co-Founder of Lazzaro Medical and Southern Region Chief of...
Dr. Richard Lazzaro recognized that there was an opportunity to create a less invasive option to treat tracheobronchomalacia (TBM) and improve the quality of life for millions of patients; in 2013, he pioneered robotically assisted, minimally invasive tracheal repair (MITR™). He later co-founded Lazzaro Medical to develop the LM Scaffold System™ which is set to further improve the treatment of Tracheobronchomalacia (TBM) by offering a minimally invasive, robotically-assisted approach that also ensures precision, safety, and effectiveness. With the recent $2.4 million Direct to Phase II SBIR grant from the NIH, Lazzaro Medical is poised to evolve TBM treatment, providing patients with a solution that addresses the root cause of their symptoms and help improve patient outcomes.